Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Neuroscience Market, by Component
1.4.2 North America Neuroscience Market, by Technology
1.4.3 North America Neuroscience Market, by End User
1.4.4 North America Neuroscience Market, by Country
1.5 Methodology for the research
Chapter 2. Market At a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Trials and Approvals
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Oct– 2023, Jul) Leading Players
4.4 Porter Five Forces Analysis
Chapter 5. North America Neuroscience Market by Component
5.1 North America Instruments Market by Country
5.2 North America Consumables Market by Country
5.3 North America Software & Services Market by Country
Chapter 6. North America Neuroscience Market by Technology
6.1 North America Brain Imaging Market by Country
6.2 North America Stereotaxic Surgeries Market by Country
6.3 North America Neuro-Microscopy Market by Country
6.4 North America Neuro-Proteomic Analysis Market by Country
6.5 North America Neuro-Cellular Manipulation Market by Country
6.6 North America Others Market by Country
Chapter 7. North America Neuroscience Market by End User
7.1 North America Diagnostic Laboratories Market by Country
7.2 North America Hospitals Market by Country
7.3 North America Research & Academic Institute Market by Country
Chapter 8. North America Neuroscience Market by Country
8.1 US Neuroscience Market
8.1.1 US Neuroscience Market by Component
8.1.2 US Neuroscience Market by Technology
8.1.3 US Neuroscience Market by End User
8.2 Canada Neuroscience Market
8.2.1 Canada Neuroscience Market by Component
8.2.2 Canada Neuroscience Market by Technology
8.2.3 Canada Neuroscience Market by End User
8.3 Mexico Neuroscience Market
8.3.1 Mexico Neuroscience Market by Component
8.3.2 Mexico Neuroscience Market by Technology
8.3.3 Mexico Neuroscience Market by End User
8.4 Rest of North America Neuroscience Market
8.4.1 Rest of North America Neuroscience Market by Component
8.4.2 Rest of North America Neuroscience Market by Technology
8.4.3 Rest of North America Neuroscience Market by End User
Chapter 9. Company Profiles
9.1 Carl Zeiss AG
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Product Launches and Product Expansions:
9.1.6 SWOT Analysis
9.2 Danaher Corporation
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Acquisition and Mergers:
9.2.6 SWOT Analysis
9.3 Abbott Laboratories
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Trials and Approvals:
9.3.5.2 Acquisition and Mergers:
9.3.6 SWOT Analysis
9.4 Koninklijke Philips N.V.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.5.2 Product Launches and Product Expansions:
9.4.5.3 Acquisition and Mergers:
9.4.6 SWOT Analysis
9.5 B. Braun Melsungen AG
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.6 SWOT Analysis
9.6 Medtronic PLC
9.6.1 Company overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expenses
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.6.6 SWOT Analysis
9.7 Boston Scientific Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Trials and Approvals:
9.7.5.2 Acquisition and Mergers:
9.7.6 SWOT Analysis
9.8 Terumo Corporation
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Partnerships, Collaborations, and Agreements:
9.8.6 SWOT Analysis
9.9 GE HealthCare Technologies, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expenses
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.6 SWOT Analysis
9.10. Stryker Corporation
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expense
9.10.5 Recent strategies and developments:
9.10.5.1 Partnerships, Collaborations, and Agreements:
9.10.5.2 Product Launches and Product Expansions:
9.10.5.3 Trials and Approvals:
9.10.6 SWOT Analysis
Unique Offerings 